NFKB1 and Insulin resistance: In addition, a study conducted in China demonstrated that liraglutide and metformin treatment in obese individuals with primary T2DM inhibited the TLR4-NF-κB signaling pathway and downregulated downstream molecules of the DAG/PKC signaling pathway, and controlling blood glucose levels or treating insulin resistance can effectively alleviate microinflammation [83].